Identification of Possible Maternal Risk Factors for Development of Syndromic Oro-Facial Clefts
Clinical Neurology and Neuroscience
Volume 3, Issue 3, September 2019, Pages: 58-65
Received: May 13, 2019; Accepted: Jun. 18, 2019; Published: Jul. 23, 2019
Views 50      Downloads 20
Authors
Coelette Smit, Department of Maxillofacial and Oral Surgery, University of Pretoria, Pretoria, South Africa; Advanced Orofacial Surgery Inc, Rosebank, South Africa
Kurt-Wilhelm Bütow, Department of Maxillofacial and Oral Surgery, University of Pretoria, Pretoria, South Africa; The Wilgers Hospital, Pretoria, South Africa
Sharan Naidoo, Department of Maxillofacial and Oral Surgery, University of Pretoria, Pretoria, South Africa
Steve Olorunju, Biostatistics Unit, South African Medical Research Council, Pretoria, South Africa
Article Tools
Follow on us
Abstract
Context: The concept “epigenetics” highlights that environmental factors are able to trigger changes in gene activity. This confounds the search for aetiological factors of syndromic oro-facial clefts as it interplays between genetics and environmental stimulation. Subjects and Methods: The study makes use of a database of syndromic cleft patients over 33 years at the Department of Maxillo-Facial and Oral Surgery at the University of Pretoria. The ten most common clefting syndromes (Fairbairn-Robin triad, Demarque van der Woude syndrome, Holoprosencephaly, Naso-maxillo-acro dysostosis (Binder’s syndrome), Goldenhar syndrome, Treacher-Collins syndrome, Trisomy 13 (Patau’s syndrome), P63 Mutation associated clefting disorders, Trisomy 21 (Down’s syndrome), Oro-Facial Digital syndromes) were included amounting to 517 patients. The nine most common maternal risk factors (Unknown Infection, Viral Infection, HIV, Medication, Smoking, Alcohol, Oligohydramnios, Vitamins, Hormones) were included totaling 398. Results: Fairbairn-Robin triad had a significant correlation with oligohydramnios, infection and medication. Demarque-van der Woude syndrome presented with a significant contribution from medication and Holoprosencephaly showed a significant correlation with vitamin supplementation. Conclusion: based on the results of this study Fairbairn-Robin triad appears to have a strong environmental component to the presentation thereof. Demarque-van der Woude was indicated to having a genetic-environmental interplay contributing to the presentation of the syndrome.
Keywords
Syndromic Oro-facial Clefts, Epigenetics, Maternal Risk Factors
To cite this article
Coelette Smit, Kurt-Wilhelm Bütow, Sharan Naidoo, Steve Olorunju, Identification of Possible Maternal Risk Factors for Development of Syndromic Oro-Facial Clefts, Clinical Neurology and Neuroscience. Vol. 3, No. 3, 2019, pp. 58-65. doi: 10.11648/j.cnn.20190303.11
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Syndrome. Definition of Syndrome by Merriam-Webster. http://www.merriam-webster.com/dictionary/syndrome. Accessed 12 Feb 2017.
[2]
Gil-da-Silva-Lopes VL, Lopes Monlleó I. Risk factors and the prevention of oral clefts. Braz Oral Res., (Sáo Paulo) 2014;18 (Spec Iss 1): 1-5.
[3]
Shi M, Wehby GL, Murray JC. Review on genetic variants and maternal smoking in the etiology of oral clefts and other birth defects. Birth Defects Research Part C: Embryo Today: Reviews, 2008; 84: 16-29.
[4]
Bütow K-W, Zwahlen RA. Cleft Ultimate treatment. 2nd Ed, Reach Publisher 2016: 441-2.
[5]
Wilkins-Haug L. Etiology, prenatal diagnosis, obstetric management, and recurrence of orofacial clefts. UpToDate 2016. https://www-uptodate-com.uplib.idm.oclc.org/contents/etiology-prenatal-diagnosis-obstetric-management-and-recurrence-of-orofacial-clefts. Jan, 2017.
[6]
Mossey PA, Little J, Munger RG, Dixon MJ, Shaw WC. Cleft lip and Palate. The Lancet, 2009; 374: 1773-85.
[7]
Sharp GC, Stergiakouli E, Sandy J, Relton C. Epigenetics and Orofacial Clefts: A Brief Introduction. Cleft Palate Craniofac J. 2017 Jan 13. doi: 10.1597/16-124. [Epub ahead of print]
[8]
Shaw GM, Wasserman CR, Lammer EJ, O’Malley CD, Murray JC, Basart AM, Tolarova MM. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet 1996; 58: 551-61.
[9]
Hwang SJ, Beaty TH, Panny SR, Street NA, Joseph JM, Gordon S, McIntosh I, Francomano CA. Association study of transforming growth factor alpha (TGF alpha) Taql polymorphism and oral clefts: indication of gene-environment interaction in a population-based sample of infants with birth defects. Am J Epidemiol 1995; 141: 629.
[10]
Shaw GM, Lammer EJ. Maternal periconceptional alcohol consumption and risk for orofacial clefts. J Pediatr 1999; 134: 298-303.
[11]
Bacino CA. Birth defects: Causes. UpToDate 2016. https://www-uptodate-com.uplib.idm.oclc.org/contents/birth-defects-causes. Accessed Jan 2017.
[12]
Chambers CD, Johnson KA, Dick LM, et al. Maternal fever and birth outcome: a prospective study. Teratology 1998; 58: 251-7.
[13]
Pleet H, Graham JM Jr, Smith DW. Central nervous system and facial defects associated with maternal hyperthermia at four to 14 weeks’ gestation. Pediatrics 1981; 67: 785-9.
[14]
Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet 2011; 157C: 175-82.
[15]
Huizink AC. Moderate use of alcohol, tobacco and cannabis during pregnancy: New approaches and update on research findings. Reprod Toxicol 2009; 28: 143-51.
[16]
Robin P. Laglossoptose. Sondiagnostic, sesconséquences, sontraitement. Bull Acad Natl Med 1923;89: 37-41. ?
[17]
Fairbairn P. Suffocation in an infant from retraction of the base of the tongue. Month J Med Sci 1846; 6: 280-1.
[18]
Bütow K-W, Zwahlen RA, Morkel JA, Naidoo S. Pierre Robin sequence: subdivision, data, theories, and treatment – Part 1: History, subdivisions, and data. Ann Maxillofac Surg 2016; 6: 31-4.
[19]
Bütow K?W, Jacobsohn PV, De Witt TW. Naso?maxillo?acro?dysostosis. S Afr Med J, 1989; 75: 5?11.
[20]
Bütow K-W, Zwahlen RA, Morkel JA, Naidoo S. Pierre Robin sequence: subdivision, data, theories, and treatment – Part 3: Prevailing controversial theories related to Pierre Robin sequence. Ann Maxillofac Surg 2016; 6: 38-43.
[21]
Figueroa AA, Glupker TJ, Fitz MG, BeGole EA. Mandible, tongue, and airway in Pierre Robin sequence: A longitudinal cephalometric study. Cleft Palate Craniofac J 1991; 28: 425-34.
[22]
Edwards JR, Newall DR. The Pierre Robin syndrome reassessed in the light of recent research. Br J Plast Surg 1985; 38: 339-42.
[23]
Butali A, Mossey PA, Adeyemo WL, Eshete ME, Gaines LA, Even D et al. Novel IRF6 mutations in families with Van Der Woude syndrome and popliteal pterygium syndrome from sub-Saharan Africa. Mol Genet Genomic Med 2014; 2: 254-60.
[24]
Peyrard-Janvid M, Leslie EJ, Kousa YA, Smith TL, Dunnwald M, Magnusson M et al. Dominant Mutations in GRHL3 Cause Van der Woude Syndrome and Disrupt Oral Periderm Development. Am J Hum Genet 2014; 94: 23-32.
[25]
Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, Watanabe Y et al. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndrome. Nat Genet 2002; 32: 285-89.
[26]
Ingraham CR, Kinoshita A, Kondo S, Yang B, Sajan S, Trout KJ, et al. Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat Genet 2006; 28: 1335-40.
[27]
Richardson RJ, Dixon J, Malhotra S, Hardman MJ, Knowles L, Boot-Handford RP, et al. Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch. Nat Genet 2006; 38: 1329-34.
[28]
Mace KA, Pearson JC, McGinnis W. An epidermal barrier wound repair pathway in Drosophilia is mediated by grainy head. Science 2005; 308: 381-5.
[29]
Ting SB, Caddy J, Hislop N, Wilanowski T, Auden A, Zhao L. A homolog of Drosophilia grainy head is essential for epidermal integrity in mice. Science 2005;308: 411-3.
[30]
Yu Z, Lin KK, Bhandari A, Spencer JA, Xu X, Wang N, et al. The Grainyhead-like epithelial transactivator Get-1/Grhl3 regulates epidermal terminal differentiation and interacts functionally with LMO4. Dev. Biol 2006; 299: 122-36.
[31]
Leoncini E, Baranello G, Orioli IM, Annerén G, Bakker M, Bianchi F. Frequency of holoprosencephaly in the international clearinghouse birth defects surveillance systems: searching for population variations. Birth Defects Res A Clin Mol Teratol 2008; 82: 585-91.
[32]
Orioli IM, Castilla EE. Epidemiology of holoprosencephaly: prevalence and risk factors. Am J Med Genet C Semin Med Genet 2010; 154C: 13-21.
[33]
Heyne GW, Everson JL, Ansen-Wilson LJ, Melberg CG, Fink DM, Parins KF, et al. Gli2 gene-environment inetractions contribute to the etiological complexity of holoprosencephaly: evidence from mouse model. Dis Model Mech 2016; 9: 1307-15.
[34]
Kietzman H, Everson JL, Sulik KK, Lipinski RJ. The teratogenic effects of prenatal ethanol exposure are exacerbated by Sonic Hedgehog or Gli2 haploinsufficiency in the mouse. 2014: PLoS ONE 9, e89448 10.1371/journal. pone.0089448 [PMCID: PMC3929747] [PubMed: 24586787].
[35]
Zuckerkandl E. Fossae praenasalis: normale und pathologische. Anat Nasenh?hle. 1st Ed. Wilhelm Braumüller, Vienna and Leipzig 1893; pp 48-52.
[36]
Binder KH. Dysostosis maxillo-nasalis, ein arhinencephaler Missbildungkomplex. Dtsch Zahnaerztl Z 1962; 17: 438-444.
[37]
Niyes FB. Case report. Angle Orthod 1939; 9: 160-65.
[38]
Olow-Nordenram M, Valentin J. An etiologic study of maxillonasal dysplasia-Binder’s syndrome. Scand J Dent Res 1987; 96: 69-74.
[39]
Howe AM, Webster WS, Lipson AH, Halliday JL, Sheffield LJ. Binder’s syndrome due to prenatal VitK deficiency: a theory of pathogenesis. Aust Dent J 1992; 37: 453-60.
[40]
Chummun S, McLean NR, Nugent M, Anderson PJ, David DJ. Binder Syndrome. J Craniofac Surg 2012; 23: 986-90.
[41]
Bogusiak K, Puch A, Arkuszewski P. Goldenhar syndrome: current perspectives. World J Pediatr 2017; 13 (5):405-15.
[42]
Maan MA, Saeed G, Akhtar SJ, Iqbal J. Goldenhar syndrome: case reports with review of literature. JPAD 2008; 18: 53-5.
[43]
Beleza-Meireles A, Hart R, Clayton-Smith J, Oliveira R, Reis CF, Vena?ncio M, et al. Oculo-auriculo-vertebral spectrum: clinical and molecular analysis of 51 patients. Eur J Med Genet 2015; 58: 455-65.
[44]
Tasse C, Bo?hringer S, Fischer S, Lu?decke HJ, Albrecht B, Horn D, et al. Oculo-auriculo-vertebral spectrum (OAVS): clinical evaluation and severity scoring of 53 patients and proposal for a new classification. Eur J Med Genet 2005; 48: 397-411.
[45]
Tasse C, Majewski F, Bo?hringer S, Fischer S, Lu?decke HJ, Gillessen-Kaesbach G, et al. A family with autosomal dominant oculo-auriculo-vertebral spectrum. Clin Dysmorphol 2007; 16: 1-7.
[46]
Vendramini-Pittoli S, Kokitsu-Nakata NM. Oculoauriculovertebral spectrum: report of nine familial cases with evidence of autosomal dominant inheritance and review of the literature. Clin Dysmorphol 2009; 18: 67-77.
[47]
Ozdemir O, Arda K, Turhan H, Tosun O. Goldenhar's syndrome. Asian Cardiovasc Thorac Ann 2002; 10: 267-69.
[48]
Kirke DK. Goldenhar's syndrome: two cases of oculo-auriculo- vertebral dysplasia occurring in full-blood Australian aboriginal sisters. Aust Paediatr J 1970; 6: 213-214.
[49]
Rosa RF, Graziadio C, Lenhardt R, Alves RP, Paskulin GA, Zen PR. Central nervous system abnormalities in patients with oculo-auriculo-vertebral spectrum (Goldenhar syndrome). Arq Neuropsiquiatr 2010; 68: 98-102.
[50]
Barisic I, Odak L, Loane M, Garne E, Wellesley D, Calzolari E, et al. Prevalence, prenatal diagnosis and clinical features of oculo-auriculo-vertebral spectrum: a registry-based study in Europe. Eur J Hum Genet 2014; 22: 1026-33.
[51]
Wieczorek D, Ludwig M, Boehringer S, Jongbloet PH, Gillessen-Kaesbach G, Horsthemke B. Reproduction abnormalities and twin pregnancies in parents of sporadic patients with oculo-auriculo-vertebral spectrum/Goldenhar syndrome. Hum Genet 2007; 121:369-76.
[52]
Hao S, Jin L, Wang H, Li C, Zheng F, Ma D, Zhang T. Mutational Analusis of TCOF1, GSC, and HOXA2 in Patients With Treatcher Collins Syndrome. J Craniofac Surg 2016; 6 (27): e583-6.
[53]
Lowry RB, Morgan K, Holmes TM, et al. Mandibulofacial dysostosis in Hutterite sibs: a possible recessive trait. Am J Med Genet 1985; 22: 501–512.
[54]
Richieri CA, Bortolozo MA, Lauris JR, et al. Mandibulofacial dysostosis: report on two Brazilian families suggesting autosomal recessive inheritance. Am J Med Genet 1993; 46: 659–64.
[55]
Witters I, van Robays J, Willekes C, Coumans A, Peeters H, Gyselaers W, Fryns JP. Trisomy 13, 18, 21 Triploidy and Turner syndrome: the 5T’s. Look at the hand. F, V & V IN OBGYN 2011; 3 (1):15-21.
[56]
Brunner HG, Hamel BCJ, van Bokhoven H. The p63 gene in EEC and other syndromes. J Med Genet 2002; 39: 377-81.
[57]
Havle A, Shedge S, Mlashetti S, Jain V. Oro-facial digital syndrome type II with otolaryngological manifestations. J Oral Maxillofac Pathol 2015; 19: 266.
[58]
Mohr OL. A hereditary lethal syndrome in man. Avh Norske Videnskad Oslo 1941; 14: 1-18.
[59]
Papillon-L E, Psaume J. Hereditary abnormality of the buccal mucosa: Abnormal bands and frenula. Revue Stomatol 1954; 55: 209–27.
[60]
Alkattan WM, Al-Qattan M, Bafaqeeh SA. The pathogenesis of the clinical features of oral-facial-digital syndrome type I. Saudi Med J 2015; 36 (11):1277-84.
[61]
Bouman A, Alders M, Oostra RJ, van Leeuwen E, Thuijs N, van der Kevie-Kersemaekers, van Maarle M. Oral-facial-digital syndrome type 1 in males: Congenital heart defects are included in its phenotypic spectrum. Am J Med Genet 2017; 173A: 1383-9.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186